# BEN-2001 in Parkinson Disease Patients With Excessive Daytime Sleepiness

> **NCT03194217** · PHASE2 · COMPLETED · sponsor: **BenevolentAI Bio** · enrollment: 244 (actual)

## Conditions studied

- Excessive Daytime Sleepiness
- Parkinson Disease

## Interventions

- **DRUG:** BEN-2001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03194217
- **Lead sponsor:** BenevolentAI Bio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-10
- **Primary completion:** 2019-05-28
- **Final completion:** 2019-05-28
- **Target enrollment:** 244 (ACTUAL)
- **Last updated:** 2025-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03194217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03194217, "BEN-2001 in Parkinson Disease Patients With Excessive Daytime Sleepiness". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03194217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*